In Depth 9 May 2022Exosome Therapy: Borrowing from Nature’s Toolbox In just a few years, exosomes have started gaining recognition as a solution to deliver treatments safely and effectively, and… May 9, 2022 - 11 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
News and Trends 1 Apr 2021Have European Investors Missed the Exosome ‘Gold Rush’? When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled that investors are taking exosome… April 1, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2020Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US big pharma Eli Lilly to… June 11, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2020Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK biotech Evox Therapeutics to develop… March 27, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email